Cytotoxic T-lymphocyte antigen 4 gene polymorphisms are associated with latent autoimmune diabetes in adults

Clinica Chimica Acta

Volumn 403, Issue 1-2, 2009, Pages 226-228

  Douroudis, K ^a   Prans, E ^a   Kisand, K ^a   Nemvalts, V ^b   Uibo, R ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b Kuressaare Hospital   (Estonia)

Author keywords

CTLA 4 (cytotoxic T lymphocyte antigen 4); LADA (latent autoimmune diabetes in adults); SNP (single nucleotide polymorphism)

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 64849101450     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.03.036     Document Type: Article

References (24)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Zimmet P.Z., Tuomi T., Mackay I.R., et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11 (1994) 299-303
3. Ueda H., Howson J.M., Esposito L., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseases. Nature 423 (2003) 506-511
4. Charlton B., and Lafferty K.J. The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 7 (1995) 793-798
5. Donner H., Rau H., Walfish P.G., et al. CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82 (1997) 143-146
6. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., and DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165 (2000) 6606-6611
7. Mochizuki M., Amemiya S., Kobayashi K., et al. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 26 (2003) 843-847
8. Haller K., Kisand K., Nemvalts V., Laine A.P., Ilonen J., and Uibo R. Type 1 diabetes is insulin-2221 MspI and CTA-4 +49 A/G polymorphism dependent. Eur J Clin Invest 34 (2004) 543-548
9. Haller K., Kisand K., Pisarev H., et al. Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens 69 (2007) 121-127
10. Tuomi T., Groop L.C., Zimmet P., Rowley M.J., Knowles W., and Mackay I.R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a noninsulin-dependent onset of disease. Diabetes 42 (1993) 359-362
11. Zimmet P.Z., Elliot R.B., Mackay I.R., Rowley M.J., Pilcher C.C., and Knowles W.J. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender. Diabet Med 11 (1994) 866-871
12. Fourlanos S., Dotta F., Greenbaum C.J., et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48 (2005) 2206-2212
13. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16 (1988) 1215
14. Torres B., Aguilar F., Franco E., et al. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 50 (2004) 2211-2215
15. Raymond M., and Rousset F. Genepop (version 3.3): population genetics software for exact tests and ecumenicism. J Heredity 86 (2001) 248
16. Purcell S., Cherny S.S., and Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
17. Gribben J.G., Freeman G.J., Boussiotis B.A., et al. CTLA4 mediates antigen-specific apoptosis of human T cells. PNAS 92 (1995) 811-815
18. Agarwal K., Jones D.E.J., Daly A.K., et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 32 (2000) 538-541
19. Barreto M., Santos E., Ferreira R., et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 12 (2004) 620-626
20. Blomhoff A., Lie B.A., Myhre A.G., et al. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 89 (2004) 3474-3476
21. Huang D., Liu L., Norén K., et al. Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 88 (1998) 192-198
22. Lei C., Dongqing Z., Yeqing S., et al. Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur J Hum Genet 13 (2005) 823-828
23. Downie-Doyle S., Bayat N., Rischmueller M., and Lester S. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome. Arthrits Rheuma 54 (2006) 2434-2440
24. Zhernakova A., Eerligh P., Barrera P., et al. CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum Genet 118 (2005) 58-66